Eco R1 Capital, LLC Allakos Inc. Transaction History

Eco R1 Capital, LLC

$2.31 Billion
Q3 2024

A detailed history of Eco R1 Capital, LLC transactions in Allakos Inc. stock. As of the latest transaction made, Eco R1 Capital, LLC holds 192,346 shares of ALLK stock, worth $248,126. This represents 0.01% of its overall portfolio holdings.

Number of Shares

192,346

Holding current value

$248,126

% of portfolio

0.01%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 14, 2024	BUY	$0.54 - $0.92 $103,866 - $176,958	192,346 New	192,346 $125,000
Q2 2023 Aug 14, 2023	BUY	$3.6 - $5.25 $2.7 Million - $3.93 Million	748,900 New	748,900 $3.27 Million

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

Bvf Inc San Francisco, CA

16.6M
Shares

$21.4 Million
0.34% of portfolio
Nea Management Company, LLC Timonium, MD

6.15M
Shares

$7.93 Million
0.31% of portfolio
Deep Track Capital, LP Greenwich, CT

5M
Shares

$6.45 Million
0.12% of portfolio
Vanguard Group Inc Valley Forge, PA

3.51M
Shares

$4.53 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

3.08M
Shares

$3.97 Million
0.13% of portfolio

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $109M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.

Account